Qingxiang Sun

23PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrochemical energy storage and conversionMolecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 14, 2026
Mechanism of CRM1 Inhibition by Lansoprazole and Its Synergy with Cisplatin in Gastric Cancer.

|Oct 08, 2025
The Role of Immune Checkpoint Inhibitors in Cancer Therapy: Mechanism and Therapeutic Advances.

Hengyi Chen, Hongling Yang, Lu Guo

|May 29, 2025
Cocrystal structure reveals the mechanism of FSP1 inhibition by FSEN1.

Sitao Zhang, Amalia H Megarioti, Joseph M Hendricks

|Oct 14, 2024
Penfluridol inhibits melanoma growth and metastasis through enhancing von Hippel‒Lindau tumor suppressor-mediated cancerous inhibitor of protein phosphatase 2A (CIP2A) degradation.

Fuyan Xu, Jiao Li, Min Ai

|Jul 25, 2024
The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside.

Xiaofei Shen, Hongling Yang, Yang Yang

|Jan 22, 2024
STK19 is a DNA/RNA-binding protein critical for DNA damage repair and cell proliferation.

Yuling Li, Yanqiu Gong, Yue Zhou

Pageof 4

Frequent Collaborators

9 joint publications

Da Jia

6 joint publications

Youfu Luo

4 joint publications

Yuqin Lei

2 joint publications

Qiao Zhou